BB - question on valuations. My understanding is that the total share count is about 413M while the float is about 358.9M. Difference being shared held in reserve (RSUs).
At our closing Friday (19.91) the MC is either $8.2B or $7.1B depending on which share count you use.
1. Which count should be used? 2. Wouldn’t AMRN have a higher multiple than 5 given anticipated growth?
Two questions BB. First you mention update of AHA/ACC SOC in 2022. Is there any reason that could not happen in 2020 or 2021?
Secondly, when you mention 1.5bn in sales for 2020 are you saying total sales for 2020 would be 1.5bn or are you saying that by the end of 2020 that the rate of sales at that point would be at a 1.5bn per year clip?